BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9024049)

  • 1. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.
    Rosenberg MK; Lebenbom-Mansour M
    Anesth Analg; 1997 Feb; 84(2):457-60. PubMed ID: 9024049
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterozygous pseudocholinesterase deficiency: a case report and review of the literature.
    Maiorana A; Roach RB
    J Oral Maxillofac Surg; 2003 Jul; 61(7):845-7. PubMed ID: 12856264
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged paralysis related to mivacurium: a case study.
    Kendrick K
    J Perianesth Nurs; 2005 Feb; 20(1):7-12. PubMed ID: 15688329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ; Gätke MR
    Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ; Gätke MR
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
    Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
    Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase.
    Vanlinthout LE; Bartels CF; Lockridge O; Callens K; Booij LH
    Anesth Analg; 1998 Nov; 87(5):1199-202. PubMed ID: 9806709
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged paralysis following sequential mivacurium administration.
    Williams M; Young RM; Milner QJ
    Anaesthesia; 2003 Oct; 58(10):1032-3. PubMed ID: 12969058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged neuromuscular block with mivacurium].
    Rodríguez-González MM; Arribas-Carrión C; Torre-Aznar C; González-Miranda F
    Rev Esp Anestesiol Reanim; 1997 Oct; 44(8):328-9. PubMed ID: 9424688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.
    Gätke MR; Ostergaard D; Bundgaard JR; Varin F; Viby-Mogensen J
    Anesthesiology; 2001 Sep; 95(3):600-6. PubMed ID: 11575530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected prolonged paralysis after mivacurium in a patient with Bamforth syndrome.
    Yildiz TS; Solak M; Baris I; Toker K
    Paediatr Anaesth; 2006 Aug; 16(8):892-4. PubMed ID: 16884476
    [No Abstract]   [Full Text] [Related]  

  • 12. Unexpected prolonged neuromuscular block after mivacurium: a case report.
    Hemadri M; Purva M; Traykova V
    Med Princ Pract; 2002; 11(1):50-2. PubMed ID: 12116697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
    Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
    Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
    Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged neuromuscular blockade caused by mivacurium].
    Péchinot M; Galloux Y
    Ann Fr Anesth Reanim; 1996; 15(5):693-4. PubMed ID: 9033774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolonged neuromuscular block induced by mivacurium].
    Bensaid A; Miloudi Y; El Harrar N
    Ann Fr Anesth Reanim; 2006 Apr; 25(4):462-3. PubMed ID: 16377125
    [No Abstract]   [Full Text] [Related]  

  • 17. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.
    Robertson WS; Shaikh J; Purdie DW
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():431-3. PubMed ID: 7486808
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged neuromuscular block after mivacurium.
    Petersen RS; Bailey PL; Kalameghan R; Ashwood ER
    Anesth Analg; 1993 Jan; 76(1):194-6. PubMed ID: 8418724
    [No Abstract]   [Full Text] [Related]  

  • 19. [Residual relaxant block due to pseudocholinesterase deficiency - First manifestation in an elderly patient].
    Zoller M; Walther S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Jan; 49(1):8-11. PubMed ID: 24446003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged mivacurium induced neuromuscular block in 5 patients homozygotic for atypical butyrylcholinesterase phenotype].
    Burnat P; Soulard D; Jacquel A; Coste T; Le Marchand P; Benoist JF
    Ann Fr Anesth Reanim; 1995; 14(6):532. PubMed ID: 8745981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.